BioCentury
ARTICLE | Financial News

Celgene invests $15M in Acetylon

February 10, 2012 1:19 AM UTC

Acetylon Pharmaceuticals Inc. (Winchester, Mass.) raised $15 million from Celgene Corp. (NASDAQ:CELG). Mark Alles, Celgene's chief commercial officer, will join Acetylon's board as a non-voting observ...